This suggests that oncogenic PTPH1 in breast cancer is a physiologically important mechanism to counteract the growth-inhibitory signal of p-EGFR/Y1173 and the intrinsic resistance to TKIs (Figure 2). The gene discussed is EGFR; the disease is breast carcinoma.